Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | CTSD | P07339 | 1/20 | 0.56 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4078013 | 0.82 | ALDH1A1 (0.64) | ALDH1A1CTSDGPR35CYP1A2CYP3A4 | |
| SCHEMBL20987678 | 0.81 | ALDH1A1 (0.63) | ALDH1A1CTSDGPR35CYP1A2CYP3A4 | |
| SCHEMBL975117 | 0.80 | ALDH1A1 (0.68) | ALDH1A1CTSDGPR35CYP1A2CYP3A4 | |
| SCHEMBL10613860 | 0.80 | ALDH1A1 (0.68) | ALDH1A1CTSDGPR35CYP1A2CYP3A4 | |
| SCHEMBL7424787 | 0.79 | ALDH1A1 (0.56) | ALDH1A1CTSDGPR35CYP1A2CYP3A4 | |
| SCHEMBL30727560 | 0.78 | TSHR (0.67) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29696138 | 0.78 | TSHR (0.67) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8592467 | 0.78 | ALDH1A1 (0.60) | ALDH1A1CTSDGPR35CYP1A2CYP3A4 | |
| SCHEMBL436389 | 0.78 | ALDH1A1 (0.66) | ALDH1A1CTSDGPR35CYP1A2CYP3A4 | |
| SCHEMBL78205 | 0.78 | TSHR (0.67) | ALDH1A1CTSDCYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108140452-B | Anisotropic conductive film and display device using the same | 国都化学株式会社 | 2020-02-18 | — | — | CN | claimed |
| US-9390831-B2 | Electronic device using anisotropic conductive composition and film | CHEIL INDUSTRIES INC. (KR) | 2016-07-12 | — | — | US | claimed |
| US-20160136286-A1 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2016-05-19 | — | — | US | claimed |
| US-8766443-B2 | Anisotropic conductive film composition, anisotropic conductive film, and semiconductor device bonded by the same | CHEIL INDUSTRIES, INC. (KR) | 2014-07-01 | — | — | US | claimed |
| US-20130154093-A1 | ANISOTROPIC CONDUCTIVE FILM COMPOSITION, ANISOTROPIC CONDUCTIVE FILM, AND SEMICONDUCTOR DEVICE BONDED BY THE SAME | KUKDO CHEMICAL CO., LTD. (KR) | 2013-06-20 | — | — | US | claimed |
| US-20130126788-A1 | Electronic device using anisotropic conductive composition and film | KUKDO CHEMICAL CO., LTD. (KR) | 2013-05-23 | — | — | US | claimed |
| US-20110165114-A1 | DRUG DELIVERY COMPOSITION | QUEEN'S UNIVERSITY OF BELFAST, THE (GB) | 2011-07-07 | — | — | US | claimed |
| EP-2300067-A2 | DRUG DELIVERY COMPOSITION | The Queen's University of Belfast (GB) | 2011-03-30 | — | — | EP | claimed |
| WO-2009147372-A2 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-12-10 | — | — | WO | claimed |
| US-20070059211-A1 | TNT sensor containing molecularly imprinted sol gel-derived films | THE COLLEGE OF WOOSTER (US) | 2007-03-15 | — | — | US | claimed |
| US-5359017-A | Using an organoiron compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1994-10-25 | — | — | US | claimed |
| EP-0511405-A1 | CATIONICALLY POLYMERIZABLE ORGANIC MATERIAL COMPOSITION AND STABILIZATION OF SAID COMPOSITION | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1992-11-04 | — | — | EP | claimed |
| JP-3237107-A | — | — | None | — | — | JP | disclosed |
| CN-117024534-A | Supermolecular high affinity protein binding system for purifying biological macromolecules | 约翰霍普金斯大学 | 2023-11-10 | — | — | CN | disclosed |
| CN-116710130-A | Protein 2 antibodies containing motile sperm domains and methods of use thereof | 脉管生物生长有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-110741017-B | Supermolecular high affinity protein binding system for purifying biological macromolecules | 约翰霍普金斯大学 | 2023-08-29 | — | — | CN | disclosed |
| JP-H03237107-A | CATIONIC POLYMERIZATION INITIATOR AND POLYMERIZABLE COMPOSITION | SANSHIN CHEM IND CO LTD | 1991-10-23 | — | — | JP | disclosed |
| EP-0295248-A1 | LIPOSOME PREPARATION AND ANTIBIOTIC. | LIPOSOME CO INC (US) | 1988-12-21 | — | — | EP | disclosed |
| EP-0295248-A4 | LIPOSOME PREPARATION AND ANTIBIOTIC. | LIPOSOME CO INC (US) | 1988-12-19 | — | — | EP | disclosed |
| WO-1988004573-A1 | LIPOSOME PREPARATION AND ANTIBIOTIC | THE LIPOSOME COMPANY, INC. (US) | 1988-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110165114-A1 | DRUG DELIVERY COMPOSITION | ECPAS, ABCB11, ABCB1 | ALDH1A1 1965/4885CTSD 4137/4885GPR35 1850/4885 |
| US-20160136286-A1 | DRUG DELIVERY COMPOSITION | ECPAS, ABCB11, ABCB1 | ALDH1A1 1965/4885CTSD 4137/4885GPR35 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.